Company news

Dimerix Limited news in 2024

Dimerix Limited's news releases, calls and decks from 2024, newest first.

View company

DMX-200 ACTION3 Phase 3 Trial Part 2 Recruitment Complete

December 29, 2024

Dimerix Receives $7.9M R&D Tax Incentive Rebate

November 14, 2024

NEPTUNE Study Network to Enhance Phase 3 Recruitment in US

October 31, 2024

Project PARASOL Update & Medical Advisory Board Appointment

October 27, 2024

ACTION3 Trial Recruitment and Multiregion Trial Site Update

September 15, 2024

First Paediatric Site Activated and Trial Update

September 11, 2024

First patient enters into Open Label Extension study

September 10, 2024

Preliminary Final Report

August 28, 2024

Adolescent Recruitment into ACTION3 Clinical Trial

July 3, 2024

Dimerix and Taiba enter into License Agreement for DMX-200

May 26, 2024

Dimerix Receives PIP Approval from the UK MHRA

April 30, 2024

Dimerix Completes $20M Placement

March 11, 2024

Dimerix Successfully Passes Efficacy Interim Analysis

March 10, 2024

PH3 Data Collection Complete for First Interim Analysis

February 26, 2024

Half-Year Financial Report & Appendix 4D - 31 December 2023

February 25, 2024

Decks in 2024